VC Cell Therapy Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
VC Cell Therapy General Information
Description
Developer of a biotechnology therapeutics designed to develop regenerative cell therapies for retinal degeneration diseases. The company produces retinal pigment epithelial cells and photoreceptor cells from allogeneic iPS cells, using automated manufacturing technology complemented with artificial intelligence analytics, enabling healthcare professionals to improve the treatments provided to patients.
Contact Information
Website
www.vcct.jpCorporate Office
- Kobe Eye Center 5th Floor
- 2-1-8 Minatojima-minamimachi, Chuo-ku
- Kobe, Hyogo 650-0047
- Japan
Corporate Office
- Kobe Eye Center 5th Floor
- 2-1-8 Minatojima-minamimachi, Chuo-ku
- Kobe, Hyogo 650-0047
- Japan
VC Cell Therapy Timeline
VC Cell Therapy Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 01-Feb-2026 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 15-Nov-2023 | Completed | Clinical Trials - Phase 1 | |||
| 1. Seed Round | 01-May-2021 | $7.33M | $7.33M | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
VC Cell Therapy Comparisons
Industry
Financing
Details
VC Cell Therapy Competitors (12)
One of VC Cell Therapy’s 12 competitors is AAVantgarde Bio, a Venture Capital-Backed company based in Rome, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AAVantgarde Bio | Venture Capital-Backed | Rome, Italy | ||||
| ONL Therapeutics | Venture Capital-Backed | Ann Arbor, MI | ||||
| AviadoBio | Venture Capital-Backed | London, United Kingdom | ||||
| AstronauTx | Venture Capital-Backed | London, United Kingdom | ||||
| jCyte | Venture Capital-Backed | Newport Beach, CA |
VC Cell Therapy Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
VC Cell Therapy Patents
VC Cell Therapy Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026075088-A1 | Cell culture device, cell pharmaceutical preparation, and method for producing cell pharmaceutical preparation | Pending | 02-Oct-2024 | ||
| EP-4803056-A1 | Transplantation device capable of encapsulating cells therein and use thereof | Pending | 30-Oct-2023 | ||
| WO-2025094914-A1 | Transplantation device capable of encapsulating cells therein and use thereof | Inactive | 30-Oct-2023 | ||
| EP-4678740-A1 | Tissue containing neural retina progenitor cells, production method thereof, and composition for treating retinal diseases comprising said tissue | Pending | 06-Mar-2023 | ||
| WO-2024185751-A1 | Tissue containing neural retina progenitor cells, production method thereof, and composition for treating retinal diseases comprising said tissue | Inactive | 06-Mar-2023 | A61P27/02 |
VC Cell Therapy Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
VC Cell Therapy Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Plus Social Investment | Impact Investing | Minority | ||
| RIMIX | Venture Capital | Minority | ||
| Dai-Dan | Corporation | Minority | ||
| Sysmex (Diagnostic Equipment) | Corporation | Minority | ||
| Yaskawa Electric | Corporation | Minority |
VC Cell Therapy FAQs
-
When was VC Cell Therapy founded?
VC Cell Therapy was founded in 2021.
-
Where is VC Cell Therapy headquartered?
VC Cell Therapy is headquartered in Kobe, Japan.
-
What is the size of VC Cell Therapy?
VC Cell Therapy has 50 total employees.
-
What industry is VC Cell Therapy in?
VC Cell Therapy’s primary industry is Biotechnology.
-
Is VC Cell Therapy a private or public company?
VC Cell Therapy is a Private company.
-
What is VC Cell Therapy’s current revenue?
The current revenue for VC Cell Therapy is .
-
How much funding has VC Cell Therapy raised over time?
VC Cell Therapy has raised $18.6M.
-
Who are VC Cell Therapy’s investors?
Plus Social Investment, RIMIX, Dai-Dan, Sysmex (Diagnostic Equipment), and Yaskawa Electric have invested in VC Cell Therapy.
-
Who are VC Cell Therapy’s competitors?
AAVantgarde Bio, ONL Therapeutics, AviadoBio, AstronauTx, and jCyte are some of the 12 competitors of VC Cell Therapy.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
